This information is intended for U.S. healthcare professionals and/or healthcare professionals involved in healthcare reimbursement. Bristol-Myers Squibb Access Support®
Indication(s)
Important Safety Information

Please indicate the disease state for which you are requesting information.

Acute Lymphoblastic Leukemia (ALL)
Metastatic Melanoma (mMelanoma) or Adjuvant Treatment of Melanoma (Adj Tx of Melanoma)
Advanced Renal Cell Carcinoma (aRCC)
Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Chronic Myeloid Leukemia (CML)
Metastatic Small Cell Lung Cancer (SCLC)
Classical Hodgkin Lymphoma (cHL)
Multiple Myeloma
Hepatocellular Carcinoma (HCC)
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Metastatic Colorectal Cancer (mCRC)
Urothelial Carcinoma (UC)

To view payer details, please visit this site from your desktop computer.

Click here to return to BMS Access Support

MMUS1901175-01-01 09/19